Page 3 - Johnathan Ford News Today

Share ABS, its cattle breeding business, is also doing well in Brazil, Russia, India and again in China. However, the firm warned that growth in the second half was likely to slow because of the growing prevalence of Covid-19 across the globe, which is causing ‘challenges for our customers and employees’. Following the update, its shares at one stage hit an all-time high of 4560p. They closed up 4.2 per cent, or 180p, at 4492p, valuing the company at £2.9billion. Stock Watch - James Croppe...

Centrica’s chief financial officer Johnathan Ford will leave the firm at the end of the month after just seven months in the role.

AstraZeneca wins approval for its COVID-19 vaccine in Pakistan and Brazil. The U.S. approves AstraZeneca's Enhertu for treatment of Gastric Cancer.

China’s economy picked up speed in the fourth quarter, helping the country to record growth of 2.3 per cent for the full year — putting it on course to be the only major economy to grow in 2020.Gross

BRITAIN-STOCKS/ (UPDATE 2):UPDATE 2-Energy, travel stocks drag FTSE 100 down

BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - U.K. stocks were little changed on Monday as the Covid vaccination program expanded to cover over-70s.Foreign minister Dominic Raab said on Sunday he remained

Chief financial officer Johnathan Ford, who had joined Centrica in June, will leave the company at the end of the month and will be replaced by Kate Ringrose, the groups financial controller.

London's FTSE 100 slipped on Monday, weighed down by falls in energy and travel stocks, while tighter restrictions on businesses led to concerns about the near-term impact on the economy.

Genus says profits surged higher in the first half, Centrica loses its CFO, Spirent says customers continue to invest in 5G during the pandemic, and PureTech announces Vor Biopharma has listed for an IPO in the US.

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any natio...